BIOSENSE ApS Financials, key figures and credit report
Gross profit 296.3 kDKK FY 2025 +137.3% vs 2024
EBIT 65.8 kDKK FY 2025 +218.9% vs 2024
Net debt - 727.6 kDKK FY 2025 +2.9% vs 2024
Quick ratio 2.7 FY 2025 +0.3 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -1.65 | 193.70 | 236.54 | 124.87 | 296.27 |
| Employee benefit expenses | -45.32 | -33.87 | - 193.75 | - 180.20 | - 230.46 |
| Total depreciation | -13.20 | ||||
| EBIT | -60.17 | 159.83 | 42.79 | -55.33 | 65.80 |
| Other financial income | 0.00 | 0.32 | 1.52 | 0.38 | |
| Other financial expenses | -3.07 | -2.50 | -0.86 | -0.82 | -0.06 |
| Pre-tax profit | -63.24 | 157.34 | 42.25 | -54.64 | 66.12 |
| Income taxes | -3.22 | -17.49 | -9.48 | 11.84 | -14.55 |
| Net earnings | -66.46 | 139.85 | 32.76 | -42.80 | 51.57 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 406.30 | 242.70 | 242.70 | 242.70 | 242.70 |
| Inventories total | 406.30 | 242.70 | 242.70 | 242.70 | 242.70 |
| Current trade debtors | 84.98 | 296.56 | 65.63 | ||
| Current other receivables | 3.70 | ||||
| Current deferred tax assets | 2.00 | 15.84 | 1.33 | ||
| Short term receivables total | 5.70 | 84.98 | 296.56 | 15.84 | 66.95 |
| Cash and bank deposits | 292.09 | 463.20 | 519.23 | 749.10 | 727.61 |
| Cash and cash equivalents | 292.09 | 463.20 | 519.23 | 749.10 | 727.61 |
| Balance sheet total (assets) | 704.10 | 790.89 | 1 058.49 | 1 007.64 | 1 037.27 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Shares repurchased | 114.40 | ||||
| Retained earnings | 502.28 | 435.82 | 575.67 | 608.43 | 565.63 |
| Profit of the financial year | -66.46 | 139.85 | 32.76 | -42.80 | 51.57 |
| Shareholders equity total | 675.22 | 700.67 | 733.43 | 690.63 | 742.21 |
| Non-current liabilities total | |||||
| Current trade creditors | 19.09 | 14.58 | 29.53 | 7.80 | 7.80 |
| Current owed to participating | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 |
| Short-term deferred tax liabilities | 17.49 | 9.48 | |||
| Other non-interest bearing current liabilities | 9.73 | 58.09 | 285.99 | 309.14 | 287.20 |
| Current liabilities total | 28.88 | 90.22 | 325.06 | 317.01 | 295.06 |
| Balance sheet total (liabilities) | 704.10 | 790.89 | 1 058.49 | 1 007.64 | 1 037.27 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated